HSKA [NASD]
Heska Corporation
Index- P/E- EPS (ttm)-1.57 Insider Own0.90% Shs Outstand10.37M Perf Week-5.48%
Market Cap652.69M Forward P/E- EPS next Y-0.15 Insider Trans0.00% Shs Float10.15M Perf Month-13.06%
Income-16.20M PEG- EPS next Q-0.03 Inst Own99.50% Short Float / Ratio9.39% / 10.53 Perf Quarter-35.46%
Sales259.00M P/S2.52 EPS this Y93.10% Inst Trans2.33% Short Interest0.95M Perf Half Y-40.13%
Book/sh39.34 P/B1.54 EPS next Y90.60% ROA-2.70% Target Price122.80 Perf Year-64.62%
Cash/sh14.93 P/C4.05 EPS next 5Y25.00% ROE-3.80% 52W Range58.00 - 189.37 Perf YTD-66.85%
Dividend- P/FCF- EPS past 5Y-15.80% ROI0.50% 52W High-68.06% Beta1.45
Dividend %- Quick Ratio5.60 Sales past 5Y14.30% Gross Margin42.90% 52W Low4.29% ATR3.77
Employees655 Current Ratio7.20 Sales Q/Q2.20% Oper. Margin-6.40% RSI (14)33.00 Volatility4.72% 5.87%
OptionableYes Debt/Eq0.24 EPS Q/Q77.40% Profit Margin-6.30% Rel Volume1.29 Prev Close62.15
ShortableYes LT Debt/Eq0.24 EarningsNov 08 BMO Payout- Avg Volume90.63K Price60.49
Recom2.50 SMA20-10.35% SMA50-15.47% SMA200-39.30% Volume118,008 Change-2.67%
Jan-06-22Resumed Piper Sandler Overweight $210
Nov-18-21Initiated Morgan Stanley Equal-Weight $190
Jul-12-21Upgrade Guggenheim Neutral → Buy $280
Oct-21-20Upgrade Raymond James Mkt Perform → Outperform $125
Aug-05-20Upgrade Piper Sandler Neutral → Overweight $87 → $110
Nov-07-19Downgrade Raymond James Outperform → Mkt Perform
Sep-18-19Initiated Piper Jaffray Neutral $68
May-23-19Initiated Guggenheim Neutral
Jul-19-18Resumed The Benchmark Company Buy $120
May-18-18Reiterated Canaccord Genuity Buy $100 → $115
Show Previous Ratings
Nov-08-22 10:53AM
09:25AM
08:00AM
Nov-03-22 08:30AM
08:10AM
10:00AM Loading…
Nov-02-22 10:00AM
Nov-01-22 10:01AM
Oct-18-22 08:00AM
Oct-11-22 11:43AM
Sep-12-22 08:42AM
08:00AM
Aug-26-22 02:23PM
Aug-19-22 08:00AM
Aug-10-22 09:27AM
Aug-09-22 08:45AM
09:25AM Loading…
Aug-08-22 09:25AM
08:00AM
Aug-02-22 10:00AM
Aug-01-22 10:01AM
Jul-25-22 06:05AM
Jul-20-22 08:00AM
Jun-22-22 11:03AM
May-25-22 08:00AM
May-09-22 09:35AM
08:00AM
May-05-22 09:25AM
May-04-22 11:21AM
07:45AM
May-02-22 03:00PM
Apr-29-22 08:00AM
08:00AM Loading…
Apr-18-22 08:00AM
Apr-14-22 08:00AM
Apr-11-22 05:52AM
Mar-29-22 08:00AM
Feb-28-22 09:25AM
08:00AM
Feb-26-22 07:53AM
Feb-24-22 08:32AM
Feb-21-22 03:00PM
Feb-20-22 07:20AM
Feb-18-22 09:06AM
Jan-31-22 08:00AM
08:00AM
Jan-14-22 12:21PM
Jan-12-22 07:03AM
Jan-03-22 08:00AM
Dec-28-21 08:00AM
Dec-09-21 08:38PM
Nov-28-21 07:15AM
Nov-04-21 03:30PM
08:00AM
Nov-02-21 08:00AM
Oct-26-21 03:32PM
Oct-14-21 08:33AM
Oct-12-21 08:00AM
Oct-01-21 09:33AM
Sep-09-21 08:00AM
Sep-08-21 08:00AM
Aug-12-21 01:06PM
Aug-03-21 06:00PM
08:00AM
Jul-26-21 04:12AM
Jul-14-21 10:40AM
Jul-13-21 11:11AM
08:00AM
Jun-11-21 03:55AM
Jun-09-21 08:11AM
May-25-21 08:00AM
May-06-21 11:00PM
09:25AM
08:00AM
Apr-27-21 03:47AM
Apr-19-21 12:42PM
Apr-16-21 08:00AM
Apr-08-21 08:00AM
Apr-01-21 06:25AM
Mar-06-21 06:40AM
Mar-02-21 10:00PM
Mar-01-21 04:05PM
Feb-25-21 11:22PM
Feb-24-21 02:53AM
Feb-23-21 03:31PM
09:26AM
08:45AM
08:00AM
Feb-16-21 08:00AM
Feb-04-21 02:29AM
Jan-26-21 08:00AM
Jan-13-21 08:00AM
Jan-12-21 04:30PM
Jan-05-21 08:30AM
Dec-21-20 01:37AM
Dec-15-20 10:29PM
Nov-24-20 08:00AM
Nov-18-20 08:00AM
Nov-05-20 03:01PM
10:45AM
08:00AM
Oct-29-20 12:35PM
Oct-15-20 08:00AM
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wisnewski NancyChief Operating OfficerSep 01Option Exercise8.5510,00085,50081,083Sep 06 03:49 PM
Baker Eleanor F.EVP, Managing Dir. & COO, scilMar 03Sale146.3466397,0253,395Mar 03 03:57 PM
Sveen David E.DirectorFeb 17Option Exercise33.068,571283,31920,546Feb 18 11:39 AM
Wilson Kevin S.CEO and PresidentFeb 11Option Exercise20.2545,149914,176132,976Feb 14 04:43 PM